Key result
Mesalazine triggers severe acute myocarditis, which rapidly resolves following drug discontinuation.
Case Report (n=1)
No
Mesalazine can induce rare but potentially severe acute myocarditis, requiring prompt recognition, drug discontinuation, and supportive care to ensure complete clinical and functional recovery.
Answers are grounded in this paper and cite their sources.
Mesalazine may trigger myocarditis in UC; this case leaves open incidence, causality, and surveillance needs.
Mesalazine-induced myocarditis, though rare, should be suspected in patients presenting with acute chest pain and elevated cardiac biomarkers shortly after treatment initiation. Cardiac MRI plays a pivotal role in diagnosis. Prompt drug discontinuation often leads to rapid clinical recovery, highlighting the importance of early recognition to prevent severe complications.
No takes yet. Share an insight, caveat, or question.
Bouayed et al. (2026) conducted a case report in Ulcerative Colitis and Acute Myocarditis (n=1). Mesalazine was evaluated on Development of acute myocarditis. A 46-year-old male developed severe acute myocarditis six days after initiating mesalazine for ulcerative colitis, which completely resolved upon discontinuation of the drug.
Synapse has enriched 10 related papers. Consider them for comparative context: